{"content":"<li class=\"n-box-item date-title\" data-end=\"1386824399\" data-start=\"1386738000\" data-txt=\"Friday, December 20, 2019\">Wednesday, December 11, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1460561\" data-ts=\"1386801909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIGM\" target=\"_blank\">SIGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460561-sigma-designs-misses-by-0_01-misses-on-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Designs misses by $0.01, misses on revenues</a></h4><ul>\n<li>Sigma Designs (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SIGM\" title=\"Sigma Designs, Inc.\">SIGM</a>): Q3 EPS of $0.10 <font color=\"red\">misses by $0.01</font>.</li>\n<li>Revenue of $54.4M (+1.2% Y/Y) <font color=\"red\">misses by $1.53M</font>. Shares  <font color=\"green\">+4.7%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460561\" data-linked=\"Sigma Designs misses by $0.01, misses on revenues\" data-tweet=\"$SIGM - Sigma Designs misses by $0.01, misses on revenues https://seekingalpha.com/news/1460561-sigma-designs-misses-by-0_01-misses-on-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/1460561-sigma-designs-misses-by-0_01-misses-on-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460541\" data-ts=\"1386801531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460541-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours Gainers / Losers</a></h4><ul>\n<li> <b> Top gainers, as of 5:15 p.m.:</b> GNCMA <font color=\"green\">+5.7%</font>. <a href=\"https://seekingalpha.com/symbol/PRTA\" title=\"Prothena Corp plc\">PRTA</a> <font color=\"green\">+5.3%</font>. <a href=\"https://seekingalpha.com/symbol/RSH\" title=\"RadioShack Corporation\">RSH</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/CAG\" title=\"ConAgra Brands, Inc.\">CAG</a> <font color=\"green\">+2.5%</font>. <a href=\"https://seekingalpha.com/symbol/KBR\" title=\"KBR, Inc.\">KBR</a> <font color=\"green\">+2.3%</font>. </li>\n<li> <b>Top losers</b><b>, as of 5:15 p.m.</b><b>:</b> <a href=\"https://seekingalpha.com/symbol/ATHN\" title=\"athenahealth, Inc.\">ATHN</a> <font color=\"red\">-14.8%</font>. <a href=\"https://seekingalpha.com/symbol/SGU\" title=\"Star Gas Partners LP.\">SGU</a> <font color=\"red\">-9.1%</font>. SUNE <font color=\"red\">-8.1%</font>. <a href=\"https://seekingalpha.com/symbol/VRA\" title=\"Vera Bradley\">VRA</a> <font color=\"red\">-5.8%</font>. <a href=\"https://seekingalpha.com/symbol/MILL\" title=\"Miller Energy Resources, Inc.\">MILL</a> <font color=\"red\">-5.6%</font>. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460541\" data-linked=\"After-hours Gainers / Losers\" data-tweet=\"$GLIBA $PRTA $RSH - After-hours Gainers / Losers https://seekingalpha.com/news/1460541-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1460541-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460531\" data-ts=\"1386801514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNVC\" target=\"_blank\">GNVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460531-genvec-plus-23_6-percent-ah-after-rac-approves-initiation-of-cgf166-phase-i-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GenVec +23.6% AH after RAC approves initiation of CGF166 phase I study</a></h4><ul>\n<li>GenVec (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GNVC\" title=\"GenVec, Inc.\">GNVC</a>) shares <font color=\"green\">spike 23.6%</font> AH after the company discloses the National Institutes of Health's Recombinant DNA Advisory Committee unanimously approved the initiation of a Phase I study of CGF166, an adenoviral vector engineered to express the atonal gene in patients with severe hearing loss. (<a href=\"http://biz.yahoo.com/e/131211/gnvc8-k.html\" target=\"_blank\">8-K</a>)</li>\n<li>CGF166 uses GenVec's adenovectors tech and is being developed by the Novartis Institute for Biomedical Institute under a research collaboration and license agreement with GenVec.</li>\n<li>An investigational new drug application is expected to be filed in Jan.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460531\" data-linked=\"GenVec +23.6% AH after RAC approves initiation of CGF166 phase I study\" data-tweet=\"$GNVC - GenVec +23.6% AH after RAC approves initiation of CGF166 phase I study https://seekingalpha.com/news/1460531-genvec-plus-23_6-percent-ah-after-rac-approves-initiation-of-cgf166-phase-i-study?source=tweet\" data-url=\"https://seekingalpha.com/news/1460531-genvec-plus-23_6-percent-ah-after-rac-approves-initiation-of-cgf166-phase-i-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460491\" data-ts=\"1386800670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460491-facebook-alliance-data-mohawk-joining-s-and-p-500\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook, Alliance Data, Mohawk joining S&amp;P 500</a></h4><ul>     <li>Better <a href=\"https://seekingalpha.com/currents/post/1445941\" target=\"_blank\">a week late</a> than never. Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) will be joining the S&amp;P 500 following the Dec. 20 close, and will also be added to the S&amp;P 100. The social networking giant is replacing test equipment vendor Teradyne (NYSE:<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a>).</li>     <li>Alliance Data Systems (NYSE:<a href='https://seekingalpha.com/symbol/ADS' title='Alliance Data Systems Corporation'>ADS</a>) and Mohawk Industries (NYSE:<a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries Inc.'>MHK</a>) are also joining the S&amp;P 500 following the Dec. 20 close. They're replacing Abercrombie &amp; Fitch (NYSE:<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a>) and JDS Uniphase (JDSU).</li>     <li><a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='green'>+3.9%</font> AH. <a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries Inc.'>MHK</a> <font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='red'>-0.8%</font>. JDSU <font color='red'>-0.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1460491\" data-linked=\"Facebook, Alliance Data, Mohawk joining S&amp;P 500\" data-tweet=\"$FB $FB $TER - Facebook, Alliance Data, Mohawk joining S&amp;P 500 https://seekingalpha.com/news/1460491-facebook-alliance-data-mohawk-joining-s-and-p-500?source=tweet\" data-url=\"https://seekingalpha.com/news/1460491-facebook-alliance-data-mohawk-joining-s-and-p-500\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460471\" data-ts=\"1386799889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IAG\" target=\"_blank\">IAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460471-iamgold-suspends-dividend-shares-minus-2_3-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IAMGOLD suspends dividend, shares -2.3% AH</a></h4><ul>     <li>IAMGOLD (NYSE:<a href=\"https://seekingalpha.com/symbol/IAG\" title=\"IAMGOLD Corporation\">IAG</a>) <font color=\"red\">-2.3%</font> AH after suspending future dividend payments until further notice.</li>     <li>CEO Steve Letwin says the company is taking the action to preserve its balance shee and allows it to conserve cash and ensure the flexibility needed \"to take advantage of opportunities when they arise.\"</li>\n<li>IAG joins the likes of Barrick Gold (ABX) and Kinross Gold (NYSE:<a href=\"https://seekingalpha.com/symbol/KGC\" title=\"Kinross Gold Corporation\">KGC</a>), which cut or suspended their dividends earlier this year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460471\" data-linked=\"IAMGOLD suspends dividend, shares -2.3% AH\" data-tweet=\"$IAG $IAG $GOLD - IAMGOLD suspends dividend, shares -2.3% AH https://seekingalpha.com/news/1460471-iamgold-suspends-dividend-shares-minus-2_3-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1460471-iamgold-suspends-dividend-shares-minus-2_3-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460421\" data-ts=\"1386799096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHN\" target=\"_blank\">ATHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460421-athenahealth-stumbles-on-weak-2014-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">athenahealth stumbles on weak 2014 outlook</a></h4><ul>\n<li>athenahealth (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ATHN\" title=\"athenahealth, Inc.\">ATHN</a>) reaffirms its FY13 outlook and provides guidance for FY14.</li>\n<li>FY13: Adjusted EPS of $1.05-1.15 on revenue of $580-615M.</li>\n<li><em>FY14: Adjusted EPS of $0.98-1.10 on revenue of $725-755M.</em></li>\n<li>Consensus for 2014 is $1.38/share on sales of $765.28M.</li>\n<li>CFO Tim Adams is \"very excited about growth opportunities and [is] pleased to present an ambitious financial plan for fiscal year 2014.\" (PR)</li>\n<li>Investors don't seem so excited: ATHN <font color=\"red\">-12%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460421\" data-linked=\"athenahealth stumbles on weak 2014 outlook\" data-tweet=\"$ATHN - athenahealth stumbles on weak 2014 outlook https://seekingalpha.com/news/1460421-athenahealth-stumbles-on-weak-2014-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1460421-athenahealth-stumbles-on-weak-2014-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460411\" data-ts=\"1386798709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460411-sunedison-issues-q4-warning-shares-minus-7_7-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunEdison issues Q4 warning, shares -7.7% AH</a></h4><ul>\n<li>SunEdison (SUNE) now expects its chip wafer division, soon to be <a href=\"https://seekingalpha.com/currents/post/1266632\" target=\"_blank\">spun off</a> in an IPO, to post Q4 revenue of $205M-$215M, down from <a href=\"https://seekingalpha.com/currents/post/1389902\" target=\"_blank\">prior guidance</a> of $220M-$230M. The company blames \"continued market weakness.\" Pricing and market share are said to be largely unchanged. (PR)</li>\n<li>SunEdison is also cutting its Q4 solar systems sales forecast to 209MW-234MW from a prior 234MW-264MW. However, the cut is simply due to a decision to keep more projects on the company's balance sheet. Completed systems guidance is unchanged at 209MW-234MW, and guidance for systems retained on SunEdison's balance sheet has been raised to 100MW-110MW from 75MW-80MW.</li>\n<li>Separately, SunEdison is announcing a debt refinancing effort. The company plans to sell $800M worth of convertible senior notes (half due in 2018, the other half in 2021), and use the proceeds to redeem $550M worth of 7.75% senior notes due 2019 and a $200M term loan sporting a 10.75% interest rate.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460411\" data-linked=\"SunEdison issues Q4 warning, shares -7.7% AH\" data-tweet=\"$SUNEQ - SunEdison issues Q4 warning, shares -7.7% AH https://seekingalpha.com/news/1460411-sunedison-issues-q4-warning-shares-minus-7_7-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1460411-sunedison-issues-q4-warning-shares-minus-7_7-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460401\" data-ts=\"1386798534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNS\" target=\"_blank\">UNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460401-uns-energy-plus-30-percent-ah-after-fortis-agrees-to-acquire-for-60_25-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UNS Energy +30% AH after Fortis agrees to acquire for $60.25/share</a></h4><ul>     <li>UNS Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/UNS\" title=\"UNS Energy Corporation\">UNS</a>) agrees to be acquired by Fortis (FRTSF), Canada's largest investor-owned gas and electric distribution utility, for $60.25/share, a 31% premium to today's closing price.</li>     <li>The $4.3B deal, which includes the assumption of ~$1.8B in debt, would provide additional capital and new resources for UNS subsidiaries including Tucson Electric Power and UniSource Energy Services.</li>     <li>Fortis serves more than 2.4M through its electric utilities in five Canadian provinces and two Caribbean countries, a natural gas company in British Columbia, and a gas and electric utility in New York.</li>\n<li>UNS <font color=\"green\">+30.2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460401\" data-linked=\"UNS Energy +30% AH after Fortis agrees to acquire for $60.25/share\" data-tweet=\"$UNS $UNS $FTS - UNS Energy +30% AH after Fortis agrees to acquire for $60.25/share https://seekingalpha.com/news/1460401-uns-energy-plus-30-percent-ah-after-fortis-agrees-to-acquire-for-60_25-share?source=tweet\" data-url=\"https://seekingalpha.com/news/1460401-uns-energy-plus-30-percent-ah-after-fortis-agrees-to-acquire-for-60_25-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460251\" data-ts=\"1386797025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460251-immunocellular-cut-in-half-as-ictminus-107-misses-primary-os-endpoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular cut in half as ICT-107 misses primary OS endpoint</a></h4><ul>\n<li>ImmunoCellular (<a href=\"https://seekingalpha.com/symbol/IMUC\" title=\"ImmunoCellular Therapeutics, Ltd.\">OTCPK:IMUC</a>) collapses <font color=\"red\">50%</font> AH.</li>\n<li>The company is out with results from a Phase 2 study of ICT-107 in newly diagnosed glioblastoma multiforme.</li>\n<li>ICT-107 showed statistically significant PFS superiority over placebo. K-M curves (entire sample of 124 patients): Favors ICT-107; HR of 0.56; p=0.014; median PFS increase was two months. K-M curves (per-protocol population): Favors ICT-107; HR of 0.53; p=0.0074; median PFS increase was three months.</li>\n<li><em>OS K-M curves fail to hit statistical significance. OS was the primary endpoint. Summary (intent-to-treat): HR of 0.87; p=0.58. Summary (per-protocol): HR of 0.79; p=0.40. <br></em></li>\n<li>For more, see here.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460251\" data-linked=\"ImmunoCellular cut in half as ICT-107 misses primary OS endpoint\" data-tweet=\"$IMUC - ImmunoCellular cut in half as ICT-107 misses primary OS endpoint https://seekingalpha.com/news/1460251-immunocellular-cut-in-half-as-ictminus-107-misses-primary-os-endpoint?source=tweet\" data-url=\"https://seekingalpha.com/news/1460251-immunocellular-cut-in-half-as-ictminus-107-misses-primary-os-endpoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460181\" data-ts=\"1386796577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNY\" target=\"_blank\">CLNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460181-good-timing-northstar-launches-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Good timing: NorthStar launches secondary offering</a></h4><ul>\n<li>NorthStar Realty Finance (NRF) takes advantage of today's <font color=\"green\">20% moonshot</font> in the stock, launching a 50M share secondary. Part of the proceeds will fund the cash portion of an approximately $400M portfolio of manufactured housing communities under contract. The rest will be for other potential investments.</li>\n<li>Shares <font color=\"red\">-4.2%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460181\" data-linked=\"Good timing: NorthStar launches secondary offering\" data-tweet=\"$CLNY - Good timing: NorthStar launches secondary offering https://seekingalpha.com/news/1460181-good-timing-northstar-launches-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1460181-good-timing-northstar-launches-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460151\" data-ts=\"1386796044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWTR\" target=\"_blank\">CWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460151-coldwater-creek-beats-by-0_13-misses-on-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coldwater Creek beats by $0.13, misses on revenues</a></h4><ul>\n<li>Coldwater Creek (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CWTR\" title=\"Coldwater Creek, Inc.\">CWTR</a>): Q3 EPS of -$0.79 <font color=\"green\">beats by $0.13</font>.</li>\n<li>Revenue of $154.5M <font color=\"red\">misses by $5.56M</font>. Shares  <font color=\"green\">+2.8%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460151\" data-linked=\"Coldwater Creek beats by $0.13, misses on revenues\" data-tweet=\"$CWTR - Coldwater Creek beats by $0.13, misses on revenues https://seekingalpha.com/news/1460151-coldwater-creek-beats-by-0_13-misses-on-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/1460151-coldwater-creek-beats-by-0_13-misses-on-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460121\" data-ts=\"1386795914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRA\" target=\"_blank\">VRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460121-vera-bradley-beats-by-0_04-beats-on-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vera Bradley beats by $0.04, beats on revenues</a></h4><ul>\n<li>Vera Bradley (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VRA\" title=\"Vera Bradley\">VRA</a>): Q3 EPS of $0.37 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $130.1M (-6% Y/Y) <font color=\"green\">beats by $0.83M</font>. Shares  <font color=\"red\">-3%</font> AH. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1460121\" data-linked=\"Vera Bradley beats by $0.04, beats on revenues\" data-tweet=\"$VRA - Vera Bradley beats by $0.04, beats on revenues https://seekingalpha.com/news/1460121-vera-bradley-beats-by-0_04-beats-on-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/1460121-vera-bradley-beats-by-0_04-beats-on-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460061\" data-ts=\"1386795519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADM\" target=\"_blank\">ADM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460061-epa-official-says-exceeding-10-percent-ethanol-in-fuel-isnt-feasible\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EPA official says exceeding 10% ethanol in fuel isn&#39;t feasible</a></h4><ul>     <li>Shares of ethanol makers slide as an EPA official tells a congressional panel it\u2019s <a href=\"http://www.bloomberg.com/news/2013-12-11/epa-official-says-exceeding-10-ethanol-in-fuel-not-feasible-1-.html\" target=\"_blank\">not feasible</a> for gasoline refiners to use as much ethanol next year as had been mandated, which is why the agency proposed easing the requirement.</li>     <li>Producers of ethanol, biodiesel and advanced biofuels have criticized the EPA\u2019s proposal, saying it undercuts a growing, domestic industry.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/ADM\" title=\"Archer Daniels Midland Co.\">ADM</a> <font color=\"red\">-1.5%</font>, <a href=\"https://seekingalpha.com/symbol/BIOF\" title=\"BioFuel Energy Corp.\">BIOF</a> <font color=\"red\">-3%</font>, <a href=\"https://seekingalpha.com/symbol/GPRE\" title=\"Green Plains Inc.\">GPRE</a> <font color=\"red\">-3.8%</font>, <a href=\"https://seekingalpha.com/symbol/REGI\" title=\"Renewable Energy Group, Inc\">REGI</a> <font color=\"red\">-4.8%</font>, <a href=\"https://seekingalpha.com/symbol/SYNM\" title=\"Syntroleum Corporation\">SYNM</a> <font color=\"red\">-5.7%</font>, <a href=\"https://seekingalpha.com/symbol/PEIX\" title=\"Pacific Ethanol, Inc.\">PEIX</a> <font color=\"red\">-9.6%</font>, <a href=\"https://seekingalpha.com/symbol/KIOR\" title=\"KiOR, Inc.\">KIOR</a> <font color=\"red\">-12.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1460061\" data-linked=\"EPA official says exceeding 10% ethanol in fuel isn&#39;t feasible\" data-tweet=\"$ADM $ADM $BIOF - EPA official says exceeding 10% ethanol in fuel isn&#39;t feasible https://seekingalpha.com/news/1460061-epa-official-says-exceeding-10-percent-ethanol-in-fuel-isnt-feasible?source=tweet\" data-url=\"https://seekingalpha.com/news/1460061-epa-official-says-exceeding-10-percent-ethanol-in-fuel-isnt-feasible\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1460051\" data-ts=\"1386795070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOR\" target=\"_blank\">FOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1460051-barrons-forestar-trades-at-a-big-discount-to-nav\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barron&#39;s: Forestar trades at a big discount to NAV</a></h4><ul>     <li>The 20% dip in Forestar (<a href=\"https://seekingalpha.com/symbol/FOR\" title=\"Forestar Group Inc.\">FOR</a> <font color=\"green\">+1.7%</font>) shares since mid-October <a href=\"http://online.barrons.com/article/SB50001424053111904009804579250212280053606.html\" target=\"_blank\">looks like a buying opportunity</a>, <em>Barron's</em> writes, as FOR sells lots and realizes income from its oil and gas properties over the next year.</li>\n<li>FOR, which owns 132K acres of real estate in 10 states  including in attractive markets in Texas, is on track to sell ~1,900 residential lots this year, more than double last year's 926 lots, and production in its burgeoning oil and gas unit is up 170% Y/Y.</li>\n<li>Proceeds from a recent equity offering, which raised $145M, while  dilutive, will further develop FOR's real estate and energy  properties in 2014, which could lead to a higher  NAV over time.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1460051\" data-linked=\"Barron&#39;s: Forestar trades at a big discount to NAV\" data-tweet=\"$FOR - Barron&#39;s: Forestar trades at a big discount to NAV https://seekingalpha.com/news/1460051-barrons-forestar-trades-at-a-big-discount-to-nav?source=tweet\" data-url=\"https://seekingalpha.com/news/1460051-barrons-forestar-trades-at-a-big-discount-to-nav\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459951\" data-ts=\"1386792500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNH\" target=\"_blank\">SNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459951-broad-slide-in-equity-reit-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broad slide in equity REIT sector</a></h4><ul>\n<li>The equity REITs are particularly weak today as the 10-year Treasury yield heads higher by 4 basis points to 2.85%. Senior Housing (<a href=\"https://seekingalpha.com/symbol/SNH\" title=\"Senior Housing Properties Trust\">SNH</a> <font color=\"red\">-2.3%</font>), Omega Healthcare (<a href=\"https://seekingalpha.com/symbol/OHI\" title=\"Omega Healthcare Investors, Inc\">OHI</a> <font color=\"red\">-2.6%</font>), American Realty Capital (ARCP <font color=\"red\">-1.7%</font>), Stag Industrial (<a href=\"https://seekingalpha.com/symbol/STAG\" title=\"STAG Industrial, Inc.\">STAG</a> <font color=\"red\">-2%</font>), Equity Residential (<a href=\"https://seekingalpha.com/symbol/EQR\" title=\"Equity Residential\">EQR</a> <font color=\"red\">-1.4%</font>).</li>\n<li>Retail and shopping center/mall REITs also have the <a href=\"https://seekingalpha.com/currents/post/1459701\" target=\"_blank\">weak retail traffic numbers</a> to mull over: Realty Income (<a href=\"https://seekingalpha.com/symbol/O\" title=\"Realty Income Corporation\">O</a> <font color=\"red\">-1.4%</font>), National Retail (<a href=\"https://seekingalpha.com/symbol/NNN\" title=\"National Retail Properties, Inc.\">NNN</a> <font color=\"red\">-2.8%</font>), Simon Property (<a href=\"https://seekingalpha.com/symbol/SPG\" title=\"Simon Property Group, Inc.\">SPG</a> <font color=\"red\">-1.4%</font>), General Growth (GGP <font color=\"red\">-2.6%</font>), Kimco (<a href=\"https://seekingalpha.com/symbol/KIM\" title=\"Kimco Realty Corporation\">KIM</a> <font color=\"red\">-2.6%</font>), Brixmor (<a href=\"https://seekingalpha.com/symbol/BRX\" title=\"Brixmor Property Group Inc.\">BRX</a> <font color=\"red\">-0.8%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459951\" data-linked=\"Broad slide in equity REIT sector\" data-tweet=\"$SNH $SNH $OHI - Broad slide in equity REIT sector https://seekingalpha.com/news/1459951-broad-slide-in-equity-reit-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/1459951-broad-slide-in-equity-reit-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459891\" data-ts=\"1386791991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOY\" target=\"_blank\">JOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459891-industrials-and-homebuilders-lead-market-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Industrials and homebuilders lead market decline</a></h4><ul>\n<li>The two worst-performing sectors on a down day are industrials (<a href=\"https://seekingalpha.com/symbol/XLI\" title=\"Industrial Select Sector SPDR ETF\">XLI</a> <font color=\"red\">-1.4%</font>) and homebuilders (<a href=\"https://seekingalpha.com/symbol/XHB\" title=\"SPDR Homebuilders ETF\">XHB</a> <font color=\"red\">-1.5%</font>), (<a href=\"https://seekingalpha.com/symbol/ITB\" title=\"iShares U.S. Home Construction ETF\">ITB</a> <font color=\"red\">-1.9%</font>).</li>\n<li>Industrials are taking a hit after Joy Global (<a href=\"https://seekingalpha.com/symbol/JOY\" title=\"Joy Global Inc.\">JOY</a> <font color=\"red\">-6.3%</font>) missed earnings estimates <a href=\"https://seekingalpha.com/currents/post/1458371\" target=\"_blank\">and provided </a>disappointing guidance. \"With a limited number of projects that can book in time to help 2014, we continue to see both the need and opportunity to lower the cost base in our business,\" says the company. Caterpillar (<a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a> <font color=\"red\">-1.2%</font>).</li>\n<li>Homebuilders continue to digest Toll Brothers' (<a href=\"https://seekingalpha.com/symbol/TOL\" title=\"Toll Brothers Inc.\">TOL</a> <font color=\"red\">-1.8%</font>) <a href=\"https://seekingalpha.com/currents/post/1456501\" target=\"_blank\">\"leveling in demand\"</a> comments from yesterday's earnings results - in the 19 weeks since August 1, business has been flat vs. last year, and in the first 5 weeks of FQ1 (beginning Nov. 1) business has also been flat from 2012 (though Hurricane Sandy makes a tricky comparison).</li>\n<li>CEO Doug Yearley on the earnings call (<a href=\"https://seekingalpha.com/article/1890401-toll-brothers-ceo-discusses-f4q-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>): \"There's just not a lot of action [this time of year]. We still feel like pent-up demand is building, demographics are on our side, affordability is in place, and we are cautiously optimistic about the spring season, which begins the end of January.\"</li>\n<li>Lennar (<a href=\"https://seekingalpha.com/symbol/LEN\" title=\"Lennar Corporation\">LEN</a> <font color=\"red\">-2.3%</font>), D. R. Horton (<a href=\"https://seekingalpha.com/symbol/DHI\" title=\"D. R. Horton Inc.\">DHI</a> <font color=\"red\">-3%</font>), KB Home (<a href=\"https://seekingalpha.com/symbol/KBH\" title=\"KB Home\">KBH</a> <font color=\"red\">-3.1%</font>), Hovnanian (<a href=\"https://seekingalpha.com/symbol/HOV\" title=\"Hovnanian Enterprises, Inc.\">HOV</a> <font color=\"red\">-3.3%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459891\" data-linked=\"Industrials and homebuilders lead market decline\" data-tweet=\"$JOY $XLI $XHB - Industrials and homebuilders lead market decline https://seekingalpha.com/news/1459891-industrials-and-homebuilders-lead-market-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/1459891-industrials-and-homebuilders-lead-market-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459861\" data-ts=\"1386791240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESRX\" target=\"_blank\">ESRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459861-deutsche-downplays-alleged-price-war-for-gilead-abbvie-hcv-drugs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche downplays alleged &quot;price war&quot; for Gilead, AbbVie HCV drugs</a></h4><ul>\n<li>\"The biggest U.S. drug benefits manager plans <a href=\"http://www.bloomberg.com/news/2013-12-10/express-scripts-pushes-price-competition-for-gilead-drug.html\" target=\"_blank\">to start a price war</a> over a new generation of hepatitis C treatments that will cost $1,000 a pill, in a bid to drive down spending on the medicines,\" Bloomberg said Tuesday, tying comments made by Express Scripts (<a href=\"https://seekingalpha.com/symbol/ESRX\" title=\"Express Scripts, Inc.\">ESRX</a> <font color=\"red\">-0.5%</font>) CMO Steven Miller to pricing for Gilead's (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"red\">-2.1%</font>) <a href=\"https://seekingalpha.com/currents/search?query=sofosbuvir\" target=\"_blank\">sofosbuvir</a> and upcoming HCV treatments from AbbVie (<a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a> <font color=\"green\">+1.2%</font>).</li>\n<li>Deutsche's Robyn Karnauskas thinks the comments might have been <a href=\"http://www.streetinsider.com/Analyst+Comments/Express+Scripts+%28ESRX%29+So-Called+%27Price+War%27+Comments+Taken+Out+of+Context+-+Analyst+%28GILD%29+%28ABBV%29/8969804.html\" target=\"_blank\">taken out of context</a> given that \"the CMO did not mention GILD or any other company/drug.\"</li>\n<li>Other takeaways from Deutsche's conversation with ESRX: The company says it \"spoke about various formulary changes and [while] HCV might be one of  them, this is not something new [as it] works on formularies everyday.\"</li>\n<li>Also: ESRX says it does not \"comment on drug/companies specifically. For Gilead drug, the internal committee still has to vote.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459861\" data-linked=\"Deutsche downplays alleged &quot;price war&quot; for Gilead, AbbVie HCV drugs\" data-tweet=\"$ESRX $ESRX $GILD - Deutsche downplays alleged &quot;price war&quot; for Gilead, AbbVie HCV drugs https://seekingalpha.com/news/1459861-deutsche-downplays-alleged-price-war-for-gilead-abbvie-hcv-drugs?source=tweet\" data-url=\"https://seekingalpha.com/news/1459861-deutsche-downplays-alleged-price-war-for-gilead-abbvie-hcv-drugs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459851\" data-ts=\"1386791007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459851-finisar-upsizes-prices-convertible-debt-offering-shares-edge-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar upsizes, prices convertible debt offering; shares edge higher</a></h4><ul>\n<li>Finisar (<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"green\">+0.7%</font>) has upsized its offering of convertible senior notes due 2033 to $225M from <a href=\"https://seekingalpha.com/currents/post/1454891\" target=\"_blank\">a prior $200M</a>. Underwriters now have a $33.75M overallotment option, up from a prior $30M. (PR)</li>\n<li>The notes carry an interest rate of just 0.5%, and have an initial conversion price of $30.18. That represents a 39% premium from current levels. Finisar can't redeem the notes before Dec. 22, 2018.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459851\" data-linked=\"Finisar upsizes, prices convertible debt offering; shares edge higher\" data-tweet=\"$FNSR - Finisar upsizes, prices convertible debt offering; shares edge higher https://seekingalpha.com/news/1459851-finisar-upsizes-prices-convertible-debt-offering-shares-edge-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1459851-finisar-upsizes-prices-convertible-debt-offering-shares-edge-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459841\" data-ts=\"1386790934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459841-gold-producers-balance-sheets-would-weaken-below-1250-oz-td-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold producers&#39; balance sheets would weaken below 1250/oz., TD says</a></h4><ul>     <li>Gold producers' balance sheets appear <a href=\"http://www.streetinsider.com/Analyst+Comments/Gold+Producers+Balance+Sheets+Would+Weaken+Below+%241250oz+%28ABX%29+%28NEM%29+%28AEM%29/8969611.html\" target=\"_blank\"> relatively stable with gold prices at ~$1,250/oz.</a> but would weaken further on lower prices, TD Securities says in an analysis of miners' sensitivity to changes in gold prices.</li>     <li>At $1,100/oz, companies with the highest forecast ratio of net debt to total capitalization include Barrick Gold (ABX <font color=\"red\">-2.5%</font>), Newmont Mining (<a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"red\">-1.9%</font>), Agnico Eagle Mines (<a href=\"https://seekingalpha.com/symbol/AEM\" title=\"Agnico Eagle Mines Limited\">AEM</a> <font color=\"red\">-2.5%</font>) and Detour Gold (<a href=\"https://seekingalpha.com/symbol/DRGDF\" title=\"Detour Gold Corp.\">OTCPK:DRGDF</a> <font color=\"green\">+3.3%</font>).</li>     <li>TD's top picks include Eldorado (<a href=\"https://seekingalpha.com/symbol/EGO\" title=\"Eldorado Gold Corporation\">EGO</a> <font color=\"red\">-3.1%</font>), Goldcorp (<a href=\"https://seekingalpha.com/symbol/GG\" title=\"Goldcorp Inc.\">GG</a> <font color=\"red\">-1.5%</font>), B2Gold (<a href=\"https://seekingalpha.com/symbol/BTG\" title=\"B2Gold Corp.\">BTG</a> <font color=\"red\">-3.7%</font>), Primero Mining (<a href=\"https://seekingalpha.com/symbol/PPP\" title=\"Primero Mining Corp. New Ordinary Shares\">PPP</a> <font color=\"red\">-0.6%</font>) and Silver Wheaton (SLW <font color=\"red\">-2%</font>).</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/GDX\" title=\"VanEck Vectors Gold Miners ETF\">GDX</a>, <a href=\"https://seekingalpha.com/symbol/GDXJ\" title=\"VanEck Vectors Junior Gold Miners ETF\">GDXJ</a>, <a href=\"https://seekingalpha.com/symbol/NUGT\" title=\"Direxion Daily Gold Miners Index Bull 3x Shares ETF\">NUGT</a>, <a href=\"https://seekingalpha.com/symbol/DUST\" title=\"Direxion Daily Gold Miners Index Bear 3x Shares ETF\">DUST</a>, GLDX, <a href=\"https://seekingalpha.com/symbol/GGGG\" title=\"Global X Pure Gold Miners ETF\">GGGG</a>, <a href=\"https://seekingalpha.com/symbol/RING\" title=\"iShares MSCI Global Gold Miners ETF\">RING</a>, <a href=\"https://seekingalpha.com/symbol/PSAU\" title=\"Invesco Global Gold and Precious Metals Portfolio ETF\">PSAU</a>, <a href=\"https://seekingalpha.com/symbol/JNUG\" title=\"Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF\">JNUG</a>, <a href=\"https://seekingalpha.com/symbol/JDST\" title=\"Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF\">JDST</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459841\" data-linked=\"Gold producers&#39; balance sheets would weaken below 1250/oz., TD says\" data-tweet=\"$GOLD $GOLD $NEM - Gold producers&#39; balance sheets would weaken below 1250/oz., TD says https://seekingalpha.com/news/1459841-gold-producers-balance-sheets-would-weaken-below-1250-oz-td-says?source=tweet\" data-url=\"https://seekingalpha.com/news/1459841-gold-producers-balance-sheets-would-weaken-below-1250-oz-td-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459801\" data-ts=\"1386789545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOR\" target=\"_blank\">WOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459801-worthington-to-close-baltimore-steel-plant-shares-minus-2_5-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Worthington to close Baltimore steel plant, shares -2.5%</a></h4><ul>     <li>Worthington (<a href=\"https://seekingalpha.com/symbol/WOR\" title=\"Worthington Industries, Inc.\">WOR</a> <font color=\"red\">-2.5%</font>) discloses that its Baltimore steel facility <a href=\"http://www.sec.gov/Archives/edgar/data/108516/000110262413001489/worthington8k.htm\" target=\"_blank\">will close</a> by the end of its 2014 fiscal year ending May 31, concluding it can more efficiently service its Mid-Atlantic customers from other company facilities and partners.</li>     <li>With the consolidation of the steel industry, many of the mills that previously supplied the Baltimore plant have closed, negatively impacting the supply  chain there, WOR says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459801\" data-linked=\"Worthington to close Baltimore steel plant, shares -2.5%\" data-tweet=\"$WOR - Worthington to close Baltimore steel plant, shares -2.5% https://seekingalpha.com/news/1459801-worthington-to-close-baltimore-steel-plant-shares-minus-2_5-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1459801-worthington-to-close-baltimore-steel-plant-shares-minus-2_5-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459791\" data-ts=\"1386789532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLB\" target=\"_blank\">DLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459791-dolby-higher-after-announcing-deals-with-fox-anchor-bay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dolby higher after announcing deals with Fox, Anchor Bay</a></h4><ul>\n<li>20th Century Fox and Anchor Bay Entertainment plan to have digital content made available via the <a href=\"http://en.wikipedia.org/wiki/UltraViolet_%28system%29\" target=\"_blank\">UltraViolet</a> DRM platform support Dolby Digital Plus (<a href=\"https://seekingalpha.com/symbol/DLB\" title=\"Dolby Laboratories, Inc.\">DLB</a> <font color=\"green\">+3.8%</font>) audio. (PR)</li>\n<li>UltraViolet, which allows purchased movies/TV shows ti be downloaded and streamed onto multiple devices, has seen a mixed reception: Disney, Apple, and certain other firms have withheld their support, and <a href=\"http://www.sltrib.com/sltrib/money/57168000-79/ultraviolet-movies-movie-service.html.csp\" target=\"_blank\">users have complained</a> about DRM restrictions and confusing download procedures.</li>\n<li>But with most major studios supporting UltraViolet and offering digital copies with Blu-ray/DVD purchases, the platform could still generate healthy licensing sales for Dolby. Shares are making new 52-week highs, and are <font color=\"green\">up 29%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459791\" data-linked=\"Dolby higher after announcing deals with Fox, Anchor Bay\" data-tweet=\"$DLB - Dolby higher after announcing deals with Fox, Anchor Bay https://seekingalpha.com/news/1459791-dolby-higher-after-announcing-deals-with-fox-anchor-bay?source=tweet\" data-url=\"https://seekingalpha.com/news/1459791-dolby-higher-after-announcing-deals-with-fox-anchor-bay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459731\" data-ts=\"1386787584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459731-gw-pharmaceuticals-gets-patent-for-use-of-cannabinoids-in-glioma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharmaceuticals gets patent for use of cannabinoids in glioma</a></h4><ul>\n<li>GW Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/GWPH\" title=\"GW Pharmaceuticals plc\">GWPH</a> <font color=\"green\">+3.4%</font>) says the USPTO has issued a patent covering \"the use of cannabinoids for treating glioma.\"</li>\n<li>Specifically, the patent covers use of a CBD/THC combo \"with the intent to reduce cell viability, inhibit cell growth, or reduce tumor volume.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459731\" data-linked=\"GW Pharmaceuticals gets patent for use of cannabinoids in glioma\" data-tweet=\"$GWPH - GW Pharmaceuticals gets patent for use of cannabinoids in glioma https://seekingalpha.com/news/1459731-gw-pharmaceuticals-gets-patent-for-use-of-cannabinoids-in-glioma?source=tweet\" data-url=\"https://seekingalpha.com/news/1459731-gw-pharmaceuticals-gets-patent-for-use-of-cannabinoids-in-glioma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459691\" data-ts=\"1386786531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459691-ja-solar-announces-management-shakeup-shares-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JA Solar announces management shakeup, shares drop</a></h4><ul>\n<li>JA Solar (<a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-3.9%</font>) COO Jian Xie is set to \"assume broader leadership\" within the company, and become its president. CTO Yong Liu will take over Xie's current job. (PR)</li>\n<li>In addition, CFO Min Cao is being reassigned to the role of chief strategy officer. Replacing him is Herman Zhao, who was JA's CFO from 2006-2008 and has since been the CFO of two other companies.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459691\" data-linked=\"JA Solar announces management shakeup, shares drop\" data-tweet=\"$JASO - JA Solar announces management shakeup, shares drop https://seekingalpha.com/news/1459691-ja-solar-announces-management-shakeup-shares-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/1459691-ja-solar-announces-management-shakeup-shares-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459671\" data-ts=\"1386786281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459671-trina-lower-after-disclosing-cfos-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trina lower after disclosing CFO&#39;s departure</a></h4><ul>\n<li>Trina (<a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-4%</font>) CFO Terry Wang is resigning, effective Jan. 10, to \"pursue other interests.\" (PR)</li>\n<li>Teresa Tan, most recently the Asia-Pac finance director for motion/control system vendor Parker-Hannfin, will replace Wang.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459671\" data-linked=\"Trina lower after disclosing CFO&#39;s departure\" data-tweet=\"$TSL - Trina lower after disclosing CFO&#39;s departure https://seekingalpha.com/news/1459671-trina-lower-after-disclosing-cfos-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/1459671-trina-lower-after-disclosing-cfos-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459591\" data-ts=\"1386784337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANDV\" target=\"_blank\">ANDV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459591-tesoro-minus-1_8-percent-despite-positive-comments-after-analyst-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesoro -1.8% despite positive comments after analyst day</a></h4><ul>     <li>Tesoro (TSO <font color=\"red\">-1.8%</font>) apparently <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/12/11/tesoro-falls-despite-positive-comments-refiners-hit\" target=\"_blank\">didn't offer enough good news</a> at yesterday's analyst day, as shares tumble despite the general perception from the meeting as \"incrementally positive.\"</li>     <li>The key messages in the meeting surrounded progress of the synergy capture from the Carson acquisition, continued margin improvement through feedstock and product optimization and driving additional logistics growth.</li>     <li>TSO sees rail unloading  capacity along the U.S. west coast for North Dakota crude oil  <a href=\"http://finance.yahoo.com/news/tesoro-west-coast-crude-rail-183352700.html\" target=\"_blank\">growing to nearly 1M bbl/day</a> through 2015; TSO's $100M rail-to-barge project in Washington is the largest of the offloading projects announced so far.</li>     <li>Imperial Capital raises its TSO price target TSO to $63 from $57, and Howard Weil lifts its target to $66 from $62.</li>     <li>Other refiners are lower too: <a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"red\">-1.3%</font>, <a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"red\">-0.7%</font>, <a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"red\">-1.8%</font>, <a href=\"https://seekingalpha.com/symbol/WNR\" title=\"Western Refining, Inc.\">WNR</a> <font color=\"red\">-2.6%</font>, <a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> <font color=\"red\">-1.6%</font>, <a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"red\">-1%</font>, <a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a> <font color=\"red\">-0.2%</font>, <a href=\"https://seekingalpha.com/symbol/DK\" title=\"Delek US Holdings, Inc.\">DK</a> <font color=\"red\">-1.9%</font>, <a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"red\">-2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459591\" data-linked=\"Tesoro -1.8% despite positive comments after analyst day\" data-tweet=\"$ANDV $ANDV $VLO - Tesoro -1.8% despite positive comments after analyst day https://seekingalpha.com/news/1459591-tesoro-minus-1_8-percent-despite-positive-comments-after-analyst-day?source=tweet\" data-url=\"https://seekingalpha.com/news/1459591-tesoro-minus-1_8-percent-despite-positive-comments-after-analyst-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459541\" data-ts=\"1386783090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459541-u-s-steel-defended-at-morgan-stanley-but-shares-minus-1_7-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel defended at Morgan Stanley, but shares -1.7%</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"red\">-1.7%</font>) has edged lower since Morgan Stanley went against the grain with its <a href=\"https://seekingalpha.com/currents/post/1409622\" target=\"_blank\">upgrade a month ago</a>, so the firm is out <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/12/11/were-not-wrong-on-u-s-steel-morgan-stanley-says\" target=\"_blank\">defending its optimistic view</a>.</li>     <li>On skepticism over X's cost cutting program, the firm believes management was right when it decided to not set a concrete cost savings target; as a result, the firm thinks each individual cost savings announcement over the coming year will be its own incremental positive catalyst, and the dispersion of announcements will make life more difficult and less predictable for short sellers.</li>     <li>The firm also says the impact of lower iron ore prices will be more than offset by improvements to earnings power from Project Carnegie cost savings, fixed cost absorption, and enhanced pricing power as operating rates rise.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459541\" data-linked=\"U.S. Steel defended at Morgan Stanley, but shares -1.7%\" data-tweet=\"$X - U.S. Steel defended at Morgan Stanley, but shares -1.7% https://seekingalpha.com/news/1459541-u-s-steel-defended-at-morgan-stanley-but-shares-minus-1_7-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1459541-u-s-steel-defended-at-morgan-stanley-but-shares-minus-1_7-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459501\" data-ts=\"1386781865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDCE\" target=\"_blank\">PDCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459501-pdc-energy-minus-6_7-percent-after-unveiling-647m-capex-budget-for-2014\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PDC Energy -6.7% after unveiling $647M capex budget for 2014</a></h4><ul>     <li>PDC Energy (<a href=\"https://seekingalpha.com/symbol/PDCE\" title=\"PDC Energy, Inc.\">PDCE</a> <font color=\"red\">-6.7%</font>) slides after announcing a 2014 capital budget of $647M, targeting organic growth within its inventory of liquid-rich projects in the core Wattenberg Field and Utica Shale.</li>     <li>Production for 2014 is seen averaging 9.5M-10M boe/day, up 34% Y/Y, with 60% in crude oil and natural gas liquids; guidance includes a reduction in dry gas volumes due to the anticipated closing of the sale of its shallow Upper Devonian assets and the suspension of drilling in its  Marcellus Shale assets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459501\" data-linked=\"PDC Energy -6.7% after unveiling $647M capex budget for 2014\" data-tweet=\"$PDCE - PDC Energy -6.7% after unveiling $647M capex budget for 2014 https://seekingalpha.com/news/1459501-pdc-energy-minus-6_7-percent-after-unveiling-647m-capex-budget-for-2014?source=tweet\" data-url=\"https://seekingalpha.com/news/1459501-pdc-energy-minus-6_7-percent-after-unveiling-647m-capex-budget-for-2014\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459461\" data-ts=\"1386781569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459461-nq-mobile-slumps-sa-contributor-criticizes-financials-conflicts-of-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile slumps; SA contributor criticizes financials, conflicts of interest</a></h4><ul>\n<li>While relying heavily on baseball analogies, SA contributor <a href=\"https://seekingalpha.com/article/1891351-research-report-what-baseball-can-teach-us-about-nq-mobile\" target=\"_blank\">Robert Zangrill</a> takes aim at NQ Mobile's (NQ <font color=\"red\">-7.1%</font>) financial metrics, as well as various conflicts of interests he sees in the company's business dealings.</li>\n<li>Zangrill notes NQ has grown its revenue/employee by 817% over the last five years, and estimates the company is \"on pace to generate about 20% more in revenue per computer than any other software company did in 2012.\"</li>\n<li>These eye-popping figures lead Zangrill to believe NQ is either \"lying about its revenue, or ... has discovered the greatest business model ever - one that requires no capital investment, no assumption of risk, not even the headache of having to deal with additional employees.\"</li>\n<li>Much like <a href=\"https://seekingalpha.com/currents/post/1353642\" target=\"_blank\">Muddy Waters</a>, Zangrill also thinks NQ is \"round tripping\" revenue via deals with affiliated parties. Among other things, he points out NQ relies on a payment processor owned by its former marketing chief, and has multiple directors with ties to a major Asian billing software provider.</li>\n<li>Shares are currently down ~50% from where they traded before Muddy Waters' allegations arrived in late October.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459461\" data-linked=\"NQ Mobile slumps; SA contributor criticizes financials, conflicts of interest\" data-tweet=\"$LKM - NQ Mobile slumps; SA contributor criticizes financials, conflicts of interest https://seekingalpha.com/news/1459461-nq-mobile-slumps-sa-contributor-criticizes-financials-conflicts-of-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/1459461-nq-mobile-slumps-sa-contributor-criticizes-financials-conflicts-of-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459411\" data-ts=\"1386780407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNY\" target=\"_blank\">CLNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459411-deutsche-a-fan-of-northstar-spinoff-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche a fan of NorthStar spinoff plan</a></h4><ul>\n<li>\"We believe the separation of the asset management business will create value for shareholders, as the management company will trade at higher multiples than the traditional mortgage REIT and real estate business,\" says analyst Stephen Laws, <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Comments+on+NorthStar+Realty+Finance+%28NRF%29+Spin-Off/8969190.html\" target=\"_blank\">reiterating his Buy</a> rating on NorthStar Realty (NRF <font color=\"green\">+16.2%</font>) after the announced spinoff plan for the asset management business.</li>\n<li>His $12.50 price target is a \"conservative valuation\" given it values the asset management business at 12x 2014 cash available for distribution - the low end of a likely range of 12-18x. He also believes CAD is likely to show continued expansion thanks to growth in the non-listed REIT business as well as potential new income streams from managing additional funds.</li>\n<li><a href=\"https://seekingalpha.com/currents/post/1458531\" target=\"_blank\">Earlier coverage</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459411\" data-linked=\"Deutsche a fan of NorthStar spinoff plan\" data-tweet=\"$CLNY - Deutsche a fan of NorthStar spinoff plan https://seekingalpha.com/news/1459411-deutsche-a-fan-of-northstar-spinoff-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/1459411-deutsche-a-fan-of-northstar-spinoff-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459371\" data-ts=\"1386778917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459371-gevo-minus-27-percent-after-raising-25m-to-restart-biofuel-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo -27% after raising $25M to restart biofuel plant</a></h4><ul>     <li>Gevo (<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a> <font color=\"red\">-27.7%</font>) plunges to 52-week lows after pricing a public offering of 18.53M common shares at $1.35 each.</li>     <li>Funds raised by the offering will be used to restart biofuel production at its facility in Luverne, Minn., and repay $5.1M in long-term debt; Gevo halted production of isobutanol in Luverne in Sept. 2012 after contamination issues prompted an adjustment of its manufacturing process.</li>     <li>Gevo cancels plans to issue convertible senior notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459371\" data-linked=\"Gevo -27% after raising $25M to restart biofuel plant\" data-tweet=\"$GEVO - Gevo -27% after raising $25M to restart biofuel plant https://seekingalpha.com/news/1459371-gevo-minus-27-percent-after-raising-25m-to-restart-biofuel-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/1459371-gevo-minus-27-percent-after-raising-25m-to-restart-biofuel-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459351\" data-ts=\"1386778674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459351-spotify-launches-new-mobile-service-adds-20-markets-pandora-drops\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spotify launches new mobile service, adds 20 markets; Pandora drops</a></h4><ul>\n<li>\n<a href=\"http://www.theverge.com/2013/12/11/5199692/spotify-announces-free-streaming-on-android-and-iphone-but-only-in\" target=\"_blank\">Spotify has launched</a> its <a href=\"https://seekingalpha.com/currents/post/1449271\" target=\"_blank\">rumored</a> free/ad-supported mobile library streaming service. As expected, the service (unlike Spotify's ad-supported PC offering) doesn't provide unfettered access to Spotify's giant music library. Rather, it allows users to stream tracks from a particular artist or featured playlist in shuffle mode.</li>\n<li>Pandora (<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"red\">-3.9%</font>), whose Web/mobile radio platform has headed off <a href=\"https://seekingalpha.com/currents/post/1063881\" target=\"_blank\">threats </a>from Spotify, Apple, and <a href=\"https://seekingalpha.com/currents/post/1025191\" target=\"_blank\">others</a>, is selling off.</li>\n<li>Spotify <a href=\"https://twitter.com/Spotify/status/410793865780539392\" target=\"_blank\">has also announced</a> it's launching its services in 20 new Latin American and Central/Eastern European markets. For now, Pandora is only available in the U.S., Australia, and New Zealand.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459351\" data-linked=\"Spotify launches new mobile service, adds 20 markets; Pandora drops\" data-tweet=\"$P - Spotify launches new mobile service, adds 20 markets; Pandora drops https://seekingalpha.com/news/1459351-spotify-launches-new-mobile-service-adds-20-markets-pandora-drops?source=tweet\" data-url=\"https://seekingalpha.com/news/1459351-spotify-launches-new-mobile-service-adds-20-markets-pandora-drops\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459301\" data-ts=\"1386778112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCW\" target=\"_blank\">ARCW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459301-arc-group-climbs-after-brean-provides-first-coverage-a-buy-and-25-pt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARC Group climbs after Brean provides first coverage: a Buy and $25 PT</a></h4><ul>\n<li>Shares of ARC Group Worldwide (<a href=\"https://seekingalpha.com/symbol/ARCW\" title=\"ARC Group Worldwide, Inc.\">ARCW</a> <font color=\"green\">+12.7%</font>) climb after Brean Capital <a href=\"http://www.streetinsider.com/Analyst+Comments/Brean+Capital+Starts+ARC+Group+Worldwide+%28ARCW%29+at+Buy%3B+Co.+Focused+on+3D+Printing/8968207.html\" target=\"_blank\">provides</a> the first analyst coverage on the name, initiating the stock at Buy with a PT of $25.</li>\n<li>Analyst Ananda Baruah adds another voice to a heated debate of whether ARCW should garner a 3D play valuation, calling the stock \"an attractive asset and an intriguing addition to our advanced technology sector coverage along with Buy-rated 3D Systems and Buy-rated Stratasys.\"</li>\n<li>Baruah sees 10%+ revenue and 15%-20% EPS growth in store for the company, with operating margin expansion opportunities.</li>\n<li>Upside includes potential for multiple expansion due to the secular attractiveness of ARCW's core Metal Injection Molding market and a \"further embrace\" by the company of 3D printing, automation, and robotics.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459301\" data-linked=\"ARC Group climbs after Brean provides first coverage: a Buy and $25 PT\" data-tweet=\"$ARCW - ARC Group climbs after Brean provides first coverage: a Buy and $25 PT https://seekingalpha.com/news/1459301-arc-group-climbs-after-brean-provides-first-coverage-a-buy-and-25-pt?source=tweet\" data-url=\"https://seekingalpha.com/news/1459301-arc-group-climbs-after-brean-provides-first-coverage-a-buy-and-25-pt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459271\" data-ts=\"1386777513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HXSCL\" target=\"_blank\">HXSCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459271-micron-sandisk-slip-hynix-plant-to-reportedly-be-operational-next-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron, SanDisk slip; Hynix plant to reportedly be operational next month</a></h4><ul>\n<li>\n<a href=\"https://twitter.com/thenotablecalls/status/410773383513526273\" target=\"_blank\">MKM reports</a> the Wuxi, China SK Hynix (<a href=\"https://seekingalpha.com/symbol/HXSCL\" title=\"SK Hynix, Inc.\">OTC:HXSCL</a>) DRAM plant that was <a href=\"https://seekingalpha.com/currents/post/1259582\" target=\"_blank\">badly damaged</a> in a September fire will be operational by mid-January, well ahead of the mid-2014 timeframe forecast by others.</li>\n<li>Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"red\">-2.1%</font>) is slipping, as is SanDisk (SNDK <font color=\"red\">-1.5%</font>), which benefits when NAND flash capacity gets reallocated to deal with DRAM shortages.</li>\n<li>Micron and SanDisk <a href=\"https://seekingalpha.com/currents/post/1454001\" target=\"_blank\">rallied on Monday</a> amid a flurry of positive DRAM sales, pricing, and supply-related news.</li>\n<li>Samsung (<a href=\"https://seekingalpha.com/symbol/SSNLF\" title=\"Samsung Electronics Co., Ltd.\">OTC:SSNLF</a>, <a href=\"https://seekingalpha.com/symbol/SSNGY\" title=\"Samsung Electronics Co., Ltd.\">OTC:SSNGY</a>), the world's largest DRAM manufacturer (<a href=\"http://english.yonhapnews.co.kr/business/2013/11/13/53/0501000000AEN20131113008100320F.html\" target=\"_blank\">37.1% Q3 share</a> per DRAMeXchange), <font color=\"green\">fell 1.4%</font> overnight in Seoul. Hynix <font color=\"green\">rose 0.8%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459271\" data-linked=\"Micron, SanDisk slip; Hynix plant to reportedly be operational next month\" data-tweet=\"$HXSCL $HXSCL $MU - Micron, SanDisk slip; Hynix plant to reportedly be operational next month https://seekingalpha.com/news/1459271-micron-sandisk-slip-hynix-plant-to-reportedly-be-operational-next-month?source=tweet\" data-url=\"https://seekingalpha.com/news/1459271-micron-sandisk-slip-hynix-plant-to-reportedly-be-operational-next-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459211\" data-ts=\"1386776692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSTG\" target=\"_blank\">NSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459211-nanostring-tech-rallies-on-expanded-availability-for-breast-cancer-diagnostic-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NanoString Tech rallies on expanded availability for breast cancer diagnostic test</a></h4><ul>\n<li>NanoString Technologies (<a href=\"https://seekingalpha.com/symbol/NSTG\" title=\"NanoString Technologies\">NSTG</a> <font color=\"green\">+16.2%</font>) is enjoying a strong session after announcing that the Prosigna Breast Cancer Prognostic Gene Signature Assay will be available nationwide in Q1 2014.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/LH\" title=\"Laboratory Corporation of America Holdings\">LH</a> and <a href=\"https://seekingalpha.com/symbol/DGX\" title=\"Quest Diagnostics Incorporated\">DGX</a> have \"chosen to add the Prosigna Assay to their comprehensive suites of breast       cancer diagnostic tests,\" NSTG notes. (PR)</li>\n<li>Meanwhile, Baird is <a href=\"http://www.streetinsider.com/New+Coverage/UPDATE%3A+Baird+Upgrades+NanoString+Tech+%28NSTG%29+to+Outperform+-+Correct/8968633.html\" target=\"_blank\">out with an upgrade</a> to Outperform from Neutral. Price target is now $18 (from $12).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459211\" data-linked=\"NanoString Tech rallies on expanded availability for breast cancer diagnostic test\" data-tweet=\"$NSTG $NSTG $LH - NanoString Tech rallies on expanded availability for breast cancer diagnostic test https://seekingalpha.com/news/1459211-nanostring-tech-rallies-on-expanded-availability-for-breast-cancer-diagnostic-test?source=tweet\" data-url=\"https://seekingalpha.com/news/1459211-nanostring-tech-rallies-on-expanded-availability-for-breast-cancer-diagnostic-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459201\" data-ts=\"1386776468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GASS\" target=\"_blank\">GASS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459201-stealthgas-will-not-proceed-with-stock-offering-shares-plus-5-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stealthgas will not proceed with stock offering, shares +5%</a></h4><ul>     <li>Stealthgas (<a href=\"https://seekingalpha.com/symbol/GASS\" title=\"StealthGas, Inc.\">GASS</a> <font color=\"green\">+4.9%</font>) decides not to proceed with its previously announced 10M-share public offering of common stock at this time, saying it is not in the best interests of shareholders.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1459201\" data-linked=\"Stealthgas will not proceed with stock offering, shares +5%\" data-tweet=\"$GASS - Stealthgas will not proceed with stock offering, shares +5% https://seekingalpha.com/news/1459201-stealthgas-will-not-proceed-with-stock-offering-shares-plus-5-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1459201-stealthgas-will-not-proceed-with-stock-offering-shares-plus-5-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459191\" data-ts=\"1386776315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVNR\" target=\"_blank\">AVNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459191-summer-street-defends-avanir-after-trial-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summer Street defends Avanir after trial miss</a></h4><ul>\n<li>Summer Street is <a href=\"http://www.streetinsider.com/Analyst+Comments/Avanir+Pharma+%28AVNR%29+Remains+Buy-Rated+at+Summer+Street%2C+Target+Cut+to+%2410/8968896.html\" target=\"_blank\">out positive</a> on Avanir Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AVNR\" title=\"Avanir Pharmaceuticals, Inc\">AVNR</a> <font color=\"red\">-19.9%</font>) as the shares sell-off on a <a href=\"https://seekingalpha.com/currents/post/1457911\" target=\"_blank\">Phase 2 miss</a> for AVP-923 in central neuropathic pain.</li>\n<li>\"Once the trial enrollment was cut in half we did not think the trial was powered for statistical significance,\" analyst Carol Werther says, adding that \"a neuropathic pain indication cannot be ruled out when positive Phase 3 results have been published in patients with type 2 diabetes.\"</li>\n<li>Werther is also upbeat on <a href=\"https://seekingalpha.com/currents/search?query=Nuedexta\" target=\"_blank\">Nuedexta</a>.</li>\n<li>Buy rating maintained.</li>\n<li>Price target cut to $10 from $17.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459191\" data-linked=\"Summer Street defends Avanir after trial miss\" data-tweet=\"$AVNR - Summer Street defends Avanir after trial miss https://seekingalpha.com/news/1459191-summer-street-defends-avanir-after-trial-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/1459191-summer-street-defends-avanir-after-trial-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459161\" data-ts=\"1386775964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLP\" target=\"_blank\">VLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459161-valero-energy-partners-up-big-after-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero Energy Partners up big after IPO</a></h4><ul>\n<li>Valero Energy Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/VLP\" title=\"Valero Energy Partners LP\">VLP</a>) is at $28 in early trades after pricing its 15M share IPO at $23 each vs. the expected range of $19-$21.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"red\">-1.4%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459161\" data-linked=\"Valero Energy Partners up big after IPO\" data-tweet=\"$VLP $VLP $VLO - Valero Energy Partners up big after IPO https://seekingalpha.com/news/1459161-valero-energy-partners-up-big-after-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/1459161-valero-energy-partners-up-big-after-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459151\" data-ts=\"1386775938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LH\" target=\"_blank\">LH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459151-labcorp-sees-its-price-targets-cut-after-delivering-weak-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LabCorp sees its price targets cut after delivering weak guidance</a></h4><ul>\n<li>Analysts are beginning to weigh in on shares of Laboratory Corporation of America (<a href=\"https://seekingalpha.com/symbol/LH\" title=\"Laboratory Corporation of America Holdings\">LH</a> <font color=\"red\">-9.1%</font>) after the company's guidance <a href=\"https://seekingalpha.com/currents/post/1457961\" target=\"_blank\">disappointed investors</a> on Tuesday evening.</li>\n<li>Canaccord has <a href=\"http://www.streetinsider.com/Downgrades/Canaccord+Genuity+Downgrades+Laboratory+Corporation+of+America+%28LH%29+to+Hold/8967816.html\" target=\"_blank\">cut the shares</a> to Hold from Buy. Price target slashed to $91 from $115.</li>\n<li>Credit Suisse <a href=\"https://twitter.com/cockrellgroup/status/410790907558887424\" target=\"_blank\">takes</a> its price target to $92 from $104.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459151\" data-linked=\"LabCorp sees its price targets cut after delivering weak guidance\" data-tweet=\"$LH - LabCorp sees its price targets cut after delivering weak guidance https://seekingalpha.com/news/1459151-labcorp-sees-its-price-targets-cut-after-delivering-weak-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1459151-labcorp-sees-its-price-targets-cut-after-delivering-weak-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459111\" data-ts=\"1386775751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRDS\" target=\"_blank\">CRDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459111-crossroads-systems-climbs-on-sa-pro-bull-articles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crossroads Systems climbs on SA Pro bull articles</a></h4><ul>\n<li>Shares of Crossroads Systems (<a href=\"https://seekingalpha.com/symbol/CRDS\" title=\"Crossroads Systems, Inc.\">CRDS</a> <font color=\"green\">+15%</font>) climb after SA Pro's Valuable Insights <a href=\"https://seekingalpha.com/article/1891681-crossroads-data-storage-turnaround-and-ip-story-could-yield-multi-bagger-return?source=email_rt_pro_article_title&amp;app=p\" target=\"_blank\">lays out the bull case</a> (embargoed until 10am ET tomorrow) for why the stock carries a \"massively asymmetric risk-reward profile.\"</li>\n<li>The potential of near-term profitability with <a href=\"https://seekingalpha.com/currents/post/1429101\" target=\"_blank\">new management</a> at the helm, a valuable IP position (a case also <a href=\"https://seekingalpha.com/article/1891691-crossroads-a-veteran-patent-stock-about-to-finally-come-of-age\" target=\"_blank\">laid out</a> by SA Pro contributor Markman Advisors), and the growth of a high-margin product could spell large upside for the company, which sports a $31.4M market cap.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459111\" data-linked=\"Crossroads Systems climbs on SA Pro bull articles\" data-tweet=\"$CRDS - Crossroads Systems climbs on SA Pro bull articles https://seekingalpha.com/news/1459111-crossroads-systems-climbs-on-sa-pro-bull-articles?source=tweet\" data-url=\"https://seekingalpha.com/news/1459111-crossroads-systems-climbs-on-sa-pro-bull-articles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459091\" data-ts=\"1386775369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDLI\" target=\"_blank\">PDLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459091-pdl-biopharma-guides-above-estimates-for-q4-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PDL BioPharma guides above estimates for Q4 revenue</a></h4><ul>\n<li>PDL BioPharma (<a href=\"https://seekingalpha.com/symbol/PDLI\" title=\"PDL BioPharma, Inc.\">PDLI</a> <font color=\"red\">-1.1%</font>) is out with revenue guidance for Q4.</li>\n<li>The company sees sales of ~$109M (+27% Y/Y). (PR)</li>\n<li>Consensus is $107.66M.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459091\" data-linked=\"PDL BioPharma guides above estimates for Q4 revenue\" data-tweet=\"$PDLI - PDL BioPharma guides above estimates for Q4 revenue https://seekingalpha.com/news/1459091-pdl-biopharma-guides-above-estimates-for-q4-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1459091-pdl-biopharma-guides-above-estimates-for-q4-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459081\" data-ts=\"1386775209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHM\" target=\"_blank\">ATHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459081-autohome-the-latest-chinese-web-ipo-to-fly-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autohome the latest Chinese Web IPO to fly higher</a></h4><ul>\n<li>After pricing its 7.82M-share IPO at $17, above a range of $14-$16, Autohome (NYSE:<a href=\"https://seekingalpha.com/symbol/ATHM\" title=\"Autohome Inc.\">ATHM</a>) opened at $30.16 and is currently at $29.97, <strong><font color=\"green\">up 76.3%</font></strong>. The Chinese automotive site owner currently has a market cap of $3.12B, or over 20x its likely 2013 sales (given recent growth rates).</li>\n<li>Over the first nine months of 2013, Autohome had revenue of $101M (+49% Y/Y), and net income of $55M. The company had over 7.7M registered users as of Sep. 30, and over 2.4M automobile listings.</li>\n<li>Other recent successful Chinese Web IPOs: <a href=\"https://seekingalpha.com/currents/post/1379022\" target=\"_blank\">Qunar</a>, <a href=\"https://seekingalpha.com/currents/post/1374952\" target=\"_blank\">58.com</a>, <a href=\"https://seekingalpha.com/currents/post/1428441\" target=\"_blank\">500.com</a>\n</li>\n<li>\n<a href=\"http://www.sec.gov/Archives/edgar/data/1527636/000119312513466042/d214139df1a.htm\" target=\"_blank\">F-1</a>, <a href=\"https://seekingalpha.com/article/1890791-ipo-preview-autohome\" target=\"_blank\">IPO preview</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459081\" data-linked=\"Autohome the latest Chinese Web IPO to fly higher\" data-tweet=\"$ATHM - Autohome the latest Chinese Web IPO to fly higher https://seekingalpha.com/news/1459081-autohome-the-latest-chinese-web-ipo-to-fly-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1459081-autohome-the-latest-chinese-web-ipo-to-fly-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459071\" data-ts=\"1386775063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459071-questcor-says-it-bought-back-500k-shares-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Questcor says it bought back 500K shares in Q4</a></h4><ul>\n<li>Along with its quarterly dividend <a href=\"https://seekingalpha.com/currents/post/1458351\" target=\"_blank\">announcement</a>, Questcor Pharmaceuticals (QCOR <font color=\"green\">+0.6%</font>) says it bought some 500K shares of its own common stock on the open market in Q4.</li>\n<li>Average price paid was $57.21. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1459071\" data-linked=\"Questcor says it bought back 500K shares in Q4\" data-tweet=\"$MNK - Questcor says it bought back 500K shares in Q4 https://seekingalpha.com/news/1459071-questcor-says-it-bought-back-500k-shares-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/1459071-questcor-says-it-bought-back-500k-shares-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1459011\" data-ts=\"1386774128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1459011-smith-and-wesson-execs-see-strong-industry-trends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smith &amp; Wesson execs see strong industry trends</a></h4><ul> <li>Smith &amp; Wesson (SWHC <font color=\"green\">+5%</font>) trades higher following its <a href=\"https://seekingalpha.com/currents/post/1457661\" target=\"_blank\">FQ2 report</a> and early look at FQ3 projections.</li> <li>Execs with the company say they expected the big drop in November for NCIS background checks, a trend they see continuing through May of next year. They note the upcoming comparables run up against an enormous period of demand and they still see industry trends as positive.</li> <li>Related stocks <a href=\"https://seekingalpha.com/symbol/RGR\" title=\"Sturm, Ruger &amp; Company Inc.\">RGR</a>, <a href=\"https://seekingalpha.com/symbol/CAB\" title=\"Cabela's Incorporated\">CAB</a>.</li>\n<li><a href=\"https://seekingalpha.com/article/1890651-smith-wesson-holding-management-discusses-q2-2014-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"1459011\" data-linked=\"Smith &amp; Wesson execs see strong industry trends\" data-tweet=\"$AOBC $AOBC $RGR - Smith &amp; Wesson execs see strong industry trends https://seekingalpha.com/news/1459011-smith-and-wesson-execs-see-strong-industry-trends?source=tweet\" data-url=\"https://seekingalpha.com/news/1459011-smith-and-wesson-execs-see-strong-industry-trends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458991\" data-ts=\"1386773765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKUS\" target=\"_blank\">RKUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458991-a-roundup-of-tech-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes</a></h4><ul><li>Ruckus (<a href='https://seekingalpha.com/symbol/RKUS' title='Ruckus Wireless'>RKUS</a> <font color='green'>+2.9%</font>) has been started at Buy by Craig-Hallum. Stephens started coverage at Overweight yesterday afternoon, Goldman upgraded shares to Buy on Dec. 2, and Stifel <a href=\"https://seekingalpha.com/currents/post/1436801\" target=\"_blank\">launched coverage</a> at Buy on Nov. 27.</li><li>Demand Media (DMD <font color='green'>+9.3%</font>) has been upgraded to Market Perform by JMP.</li><li>Radware (<a href='https://seekingalpha.com/symbol/RDWR' title='Radware Ltd.'>RDWR</a> <font color='green'>+2.5%</font>) has been upgraded to Outperform by Wells Fargo.</li><li>E2open (<a href='https://seekingalpha.com/symbol/EOPN' title='E2open'>EOPN</a> <font color='green'>+2.2%</font>) has been started at Buy by Janney.</li></ul><div class=\"tiny-share-widget\" data-id=\"1458991\" data-linked=\"A roundup of tech ratings changes\" data-tweet=\"$RKUS $RKUS $LEAF - A roundup of tech ratings changes https://seekingalpha.com/news/1458991-a-roundup-of-tech-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1458991-a-roundup-of-tech-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458901\" data-ts=\"1386772227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNI\" target=\"_blank\">SNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458901-more-signs-discovery-scripps-networks-deal-wont-fly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More signs Discovery-Scripps Networks deal won&#39;t fly</a></h4><ul> <li>Scripps Networks Interactive (NYSE:<a href=\"https://seekingalpha.com/symbol/SNI\" title=\"Scripps Networks Interactive, Inc.\">SNI</a>) and Discovery Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DISCA\" title=\"Discovery Inc A\">DISCA</a>) <a href=\"https://twitter.com/kaylatausche/status/410776358323638272\" target=\"_blank\">aren't actively discussing</a> a merger, according to CNBC.</li> <li><a href=\"https://seekingalpha.com/currents/search?query=disca%20sni\" target=\"_blank\">DISCA-SNI timeline</a></li> <li>SNI <font color=\"green\">+5.6%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1458901\" data-linked=\"More signs Discovery-Scripps Networks deal won&#39;t fly\" data-tweet=\"$SNI $SNI $DISCA - More signs Discovery-Scripps Networks deal won&#39;t fly https://seekingalpha.com/news/1458901-more-signs-discovery-scripps-networks-deal-wont-fly?source=tweet\" data-url=\"https://seekingalpha.com/news/1458901-more-signs-discovery-scripps-networks-deal-wont-fly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458841\" data-ts=\"1386771300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISCA\" target=\"_blank\">DISCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458841-analysis-a-discovery-communications-scripps-deal-is-no-sure-thing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysis: A Discovery Communications-Scripps deal is no sure thing</a></h4><ul> <li>Sterne Agee doesn't think Discovery Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DISCA\" title=\"Discovery Inc A\">DISCA</a>) will end up buying Scripps Networks Interactive (NYSE:<a href=\"https://seekingalpha.com/symbol/SNI\" title=\"Scripps Networks Interactive, Inc.\">SNI</a>).</li> <li>The investment firm <a href=\"https://twitter.com/thenotablecalls/status/410770500357324800\" target=\"_blank\">rates</a> the chances of a deal at 10% with the <em>Variety</em> report perhaps overstating the level of interest by Discovery to buck up.</li> <li>SNI has peeled back some of its gains with some of the bloom off the rose, <font color=\"green\">up 5.9%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1458841\" data-linked=\"Analysis: A Discovery Communications-Scripps deal is no sure thing\" data-tweet=\"$DISCA $DISCA $SNI - Analysis: A Discovery Communications-Scripps deal is no sure thing https://seekingalpha.com/news/1458841-analysis-a-discovery-communications-scripps-deal-is-no-sure-thing?source=tweet\" data-url=\"https://seekingalpha.com/news/1458841-analysis-a-discovery-communications-scripps-deal-is-no-sure-thing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458831\" data-ts=\"1386771073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458831-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CYTR' title='CytRx Corporation'>CYTR</a> <font color='green'>+60%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+24%</font>. NRF <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ECTE' title='Echo Therapeutics'>OTC:ECTE</a> <font color='green'>+18%</font>. FREE <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BGMD' title='BG Medicine, Inc.'>OTC:BGMD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ARCW' title='ARC Group Worldwide, Inc.'>ARCW</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SNI' title='Scripps Networks Interactive, Inc.'>SNI</a> <font color='green'>+6%</font>. SWHC <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/AVNR' title='Avanir Pharmaceuticals, Inc'>AVNR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/LH' title='Laboratory Corporation of America Holdings'>LH</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"1458831\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$CYTR $LIVE $CLNY - Premarket Gainers / Losers https://seekingalpha.com/news/1458831-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1458831-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458761\" data-ts=\"1386769765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBI\" target=\"_blank\">CBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458761-cb-and-i-reaffirms-2013-guidance-sees-2014-eps-and-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CB&amp;I reaffirms 2013 guidance, sees 2014 EPS and revenue in-line</a></h4><ul>     <li>CB&amp;I (NYSE:<a href=\"https://seekingalpha.com/symbol/CBI\" title=\"Chicago Bridge &amp; Iron Company\">CBI</a>) <a href=\"http://www.sec.gov/Archives/edgar/data/1027884/000114420413066627/v362698_ex99-2.htm\" target=\"_blank\">reaffirms guidance for 2013</a>, seeing EPS of $4.00-$4.35 vs.  $4.16 consensus estimate and revenue of $10.7B-$11.2B vs. $11.17B consensus.</li>     <li>Issues in-line guidance for 2014, seeing EPS of $4.80-$5.65 vs. $5.16 consensus estimate and revenue of $12.6B-$13.2B vs. $12.98B consensus. (<a href=\"http://www.sec.gov/Archives/edgar/data/1027884/000114420413066627/v362698_ex99-1.htm\" target=\"_blank\">Investor Day slides</a>)</li>\n<li>CBI <font color=\"green\">+1.9%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1458761\" data-linked=\"CB&amp;I reaffirms 2013 guidance, sees 2014 EPS and revenue in-line\" data-tweet=\"$CBI - CB&amp;I reaffirms 2013 guidance, sees 2014 EPS and revenue in-line https://seekingalpha.com/news/1458761-cb-and-i-reaffirms-2013-guidance-sees-2014-eps-and-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/1458761-cb-and-i-reaffirms-2013-guidance-sees-2014-eps-and-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458741\" data-ts=\"1386769392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URBN\" target=\"_blank\">URBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458741-urban-outfitters-busts-out-of-retail-malaise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urban Outfitters busts out of retail malaise</a></h4><ul> <li>Urban Outfitters (NASDAQ:<a href=\"https://seekingalpha.com/symbol/URBN\" title=\"Urban Outfitters, Inc.\">URBN</a>) gains after <a href=\"https://seekingalpha.com/currents/post/1457831\" target=\"_blank\">disclosing</a> it's running a rosy-sounding mid single-digit comp for FQ4.</li> <li>What to watch: The solid report isn't expected to give a lift to the sector, according to analysts. The out-performance compared to other mall-based retailers could be based on the company's vibrant e-commerce business and an assortment that is seen as fashion-forward.</li> <li>URBN <font color=\"green\">+4.1%</font> premarket to $37.20.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1458741\" data-linked=\"Urban Outfitters busts out of retail malaise\" data-tweet=\"$URBN - Urban Outfitters busts out of retail malaise https://seekingalpha.com/news/1458741-urban-outfitters-busts-out-of-retail-malaise?source=tweet\" data-url=\"https://seekingalpha.com/news/1458741-urban-outfitters-busts-out-of-retail-malaise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458731\" data-ts=\"1386769365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPPI\" target=\"_blank\">SPPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458731-spectrum-pharma-outlines-marqibo-folotyn-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Pharma outlines Marqibo, Folotyn studies</a></h4><ul>\n<li>Spectrum Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPPI\" title=\"Spectrum Pharmaceuticals, Inc.\">SPPI</a>) is up <font color=\"green\">5%</font> in premarket action.</li>\n<li>Out Wednesday morning are what the company calls \"encouraging\" data from <a href=\"https://seekingalpha.com/currents/search?query=Marqibo\" target=\"_blank\">Marqibo</a> and Folotyn studies.</li>\n<li>Results from a Phase 2 study suggest Marqibo could have utility in the treatment of diffuse large       B-cell lymphoma\" (front-line). Summary: Marqibo substituted for Vincristin in R-CHOP; ORR, 95%; CRR, 90%; 10-year PFS, 64%; 10-year OS, 87%.</li>\n<li>As for Folotyn, data suggest the drug \"may provide benefit to patients with early       stage peripheral T-cell lymphoma.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458731\" data-linked=\"Spectrum Pharma outlines Marqibo, Folotyn studies\" data-tweet=\"$SPPI - Spectrum Pharma outlines Marqibo, Folotyn studies https://seekingalpha.com/news/1458731-spectrum-pharma-outlines-marqibo-folotyn-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/1458731-spectrum-pharma-outlines-marqibo-folotyn-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458651\" data-ts=\"1386768315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AABA\" target=\"_blank\">AABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458651-alibaba-signals-delay-in-ipo-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba signals delay in IPO plans</a></h4><ul>\n<li>Likely signaling a sizable delay in the timing of its IPO, Alibaba is reportedly seeking to extend the draw-down period of an $8B loan to December of next year (from January).</li>\n<li>\"We have plenty of cash on the balance sheet and there is no need to draw down at this time, so we are extending the availability of funds to maintain flexibility,\" the company says.</li>\n<li>YHOO <font color=\"red\">-0.6%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458651\" data-linked=\"Alibaba signals delay in IPO plans\" data-tweet=\"$AABA - Alibaba signals delay in IPO plans https://seekingalpha.com/news/1458651-alibaba-signals-delay-in-ipo-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/1458651-alibaba-signals-delay-in-ipo-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458641\" data-ts=\"1386768223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTR\" target=\"_blank\">CYTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458641-cytrx-reports-positive-top-line-data-from-aldoxorubicin-sts-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CytRx reports positive top-line data from aldoxorubicin STS trial</a></h4><ul>\n<li>CytRx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CYTR\" title=\"CytRx Corporation\">CYTR</a>) is out with top-line results from a Phase 2b study of <a href=\"https://seekingalpha.com/currents/search?query=aldoxorubicin\" target=\"_blank\">aldoxorubicin</a> in first-line metastatic, locally advanced or unresectable STSs.</li>\n<li>Summary (intent-to-treat analysis): Median PFS for aldoxorubicin, 8.4 months; median PFS for doxorubicin, 4.7 months.</li>\n<li>Summary (blinded central lab review): Median PFS for       aldoxorubicin, 5.7 months; median PFS for doxorubicin, 2.8 months.</li>\n<li>OR rate: 25.4% for aldoxorubicin, 5.4% for doxorubicin.</li>\n<li>\"These results are extraordinary for a single agent treating these       chemotherapy-resistant tumors,\" the study's principal investigator says. (PR)</li>\n<li>CYTR <font color=\"green\">+32%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458641\" data-linked=\"CytRx reports positive top-line data from aldoxorubicin STS trial\" data-tweet=\"$CYTR - CytRx reports positive top-line data from aldoxorubicin STS trial https://seekingalpha.com/news/1458641-cytrx-reports-positive-top-line-data-from-aldoxorubicin-sts-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1458641-cytrx-reports-positive-top-line-data-from-aldoxorubicin-sts-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458611\" data-ts=\"1386767468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECTE\" target=\"_blank\">ECTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458611-echo-therapeutics-rises-on-chinese-licensing-deal-for-symphony-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Echo Therapeutics rises on Chinese licensing deal for Symphony System</a></h4><ul>\n<li>After rallying <font color=\"green\">8%</font> Tuesday, shares of Echo Therapeutics (<a href=\"https://seekingalpha.com/symbol/ECTE\" title=\"Echo Therapeutics\">OTC:ECTE</a>) are up some <font color=\"green\">26% </font>in premarket action.</li>\n<li>The company has inked a licensing, development, and commercialization agreement with Medical Technologies Innovation Asia for the manufacture and distribution of the <a href=\"https://seekingalpha.com/currents/search?query=Symphony\" target=\"_blank\">Symphony</a> CGM System in China, Hong Kong, Macau, and Taiwan.</li>\n<li>Medical Technologies Innovation will take on the development, marketing, and manufacturing costs for the Chinese market, and will also be responsible for  \"obtaining regulatory approval for the product in the licensed  territories.\"</li>\n<li>Medical Technologies Innovation is also entitled to $1.5M in development cost reimbursement, payable in ECTE stock.</li>\n<li>The companies will share any net sales of the system in the region. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458611\" data-linked=\"Echo Therapeutics rises on Chinese licensing deal for Symphony System\" data-tweet=\"$ECTE - Echo Therapeutics rises on Chinese licensing deal for Symphony System https://seekingalpha.com/news/1458611-echo-therapeutics-rises-on-chinese-licensing-deal-for-symphony-system?source=tweet\" data-url=\"https://seekingalpha.com/news/1458611-echo-therapeutics-rises-on-chinese-licensing-deal-for-symphony-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458601\" data-ts=\"1386767326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHCP\" target=\"_blank\">DHCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458601-walter-gains-after-msr-acquistion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walter gains after MSR acquistion</a></h4><ul>\n<li>Walter Investment Management (WAC) is <font color=\"green\">up 1.7%</font> premarket after agreeing to buy MSRs with about $30B in UPB from \"a large national depository.\"</li>\n<li>The portfolio consists of about 270K accounts - projected to be 99% current - and includes more than 100K HARP-eligible mortgages. The transfers are expected to occur in staged boardings in the first three quarters of 2014.</li>\n<li>Management's plan is to acquire MSRs with UPB of about $62B, and, to date, the company has entered into agreements for about $54B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458601\" data-linked=\"Walter gains after MSR acquistion\" data-tweet=\"$DHCP - Walter gains after MSR acquistion https://seekingalpha.com/news/1458601-walter-gains-after-msr-acquistion?source=tweet\" data-url=\"https://seekingalpha.com/news/1458601-walter-gains-after-msr-acquistion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458591\" data-ts=\"1386767289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458591-costco-lower-after-expenses-cut-into-profits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco lower after expenses cut into profits</a></h4><ul>     <li>Costco (NASDAQ:<a href=\"https://seekingalpha.com/symbol/COST\" title=\"Costco Wholesale Corporation\">COST</a>) slips in early trading after an increase in expenses cut into profitability during the retailer's <a href=\"https://seekingalpha.com/currents/post/1458151\" target=\"_blank\">FQ1</a>.</li>     <li>Retail analysts are still finding <a href=\"https://twitter.com/Retail_Guru/status/410753765960990720\" target=\"_blank\">plenty to like</a> in Costco's report. For starters, amid a promotional retail atmosphere selling margin was higher and membership income grew at a nice clip during the period.</li>     <li>An important note on Costco (<a href=\"https://seekingalpha.com/article/1891311-costco-black-friday-was-late-this-year-and-is-being-felt-in-the-financial-results\" target=\"_blank\">h/t</a> SA contributor The Investment Doctor): This year's FQ1 doesn't include Black Friday like it did last year.</li>     <li>COST <font color=\"red\">-2.5%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1458591\" data-linked=\"Costco lower after expenses cut into profits\" data-tweet=\"$COST - Costco lower after expenses cut into profits https://seekingalpha.com/news/1458591-costco-lower-after-expenses-cut-into-profits?source=tweet\" data-url=\"https://seekingalpha.com/news/1458591-costco-lower-after-expenses-cut-into-profits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458531\" data-ts=\"1386766505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNY\" target=\"_blank\">CLNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458531-northstar-flies-on-spinoff-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NorthStar flies on spinoff plan</a></h4><ul>\n<li>NorthStar Realty (NRF) is now <font color=\"green\">ahead 16.7%</font> in the premarket <a href=\"https://seekingalpha.com/currents/post/1457461\" target=\"_blank\">following its plan</a> to spin off its asset management business.</li>\n<li>The <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=185725&amp;p=irol-irhome\" target=\"_blank\">conference call</a> is set for 10 ET, but <a href=\"http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTI3ODY3fENoaWxkSUQ9MjE0Nzg5fFR5cGU9MQ==&amp;t=1\" target=\"_blank\">the presentation slides</a> are currently available.</li>\n<li>Certainly working at the moment is page 14 of the presentation which compares NRF's P/E multiple (8.3x) with that of what it picks out as competitors - Real Estate Managers (19.4x), Small Traditional Asset Managers (19.9x), MLP GPs (35.1x), and Altisource Asset Management (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/AAMC\" title=\"Altisource Asset Management Corp\">AAMC</a>) at 50.1x.</li>\n<li>The comps may or may not make sense, but if NorthStar Asset Management is anything like the Altisource Asset Management spinoff, investors would be wise to get in early ... in size. AAMC's more than a 10-bagger since being spun off from Altisource Portfolio Solutions (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ASPS\" title=\"Altisource Portfolio Solutions SA\">ASPS</a>) one year ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458531\" data-linked=\"NorthStar flies on spinoff plan\" data-tweet=\"$CLNY $CLNY $AAMC - NorthStar flies on spinoff plan https://seekingalpha.com/news/1458531-northstar-flies-on-spinoff-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/1458531-northstar-flies-on-spinoff-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458501\" data-ts=\"1386766138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVNR\" target=\"_blank\">AVNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458501-mizuho-downgrades-avanir-after-prime-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho downgrades Avanir after PRIME miss</a></h4><ul>\n<li>Mizuho <a href=\"https://twitter.com/biostocks/status/410747180756893697\" target=\"_blank\">cuts</a> Avanir Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AVNR\" title=\"Avanir Pharmaceuticals, Inc\">AVNR</a>) to Neutral from Buy on the heels of Tuesday evening's news that AVP-923 missed its efficacy endpoint in MS-associated central neuropathic pain.</li>\n<li>Price target is now $5 (from $11).</li>\n<li>AVNR <font color=\"red\">-14%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458501\" data-linked=\"Mizuho downgrades Avanir after PRIME miss\" data-tweet=\"$AVNR - Mizuho downgrades Avanir after PRIME miss https://seekingalpha.com/news/1458501-mizuho-downgrades-avanir-after-prime-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/1458501-mizuho-downgrades-avanir-after-prime-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458441\" data-ts=\"1386765126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458441-groupon-gains-amid-positive-sell-side-calls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon gains amid positive sell-side calls</a></h4><ul>\n<li>Wells Fargo upgrades to Groupon (<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a> <font color=\"green\">+2.4%</font>) to Buy and raises its price target to $13-$14 from $5-$6. \"We believe Groupon is positioned well to take continued share in the massive local commerce market,\" says analyst Trisha Dill. \"We are bullish on the company\u2019s strategy to transform into a \u201cpull\u201d marketplace, away from its daily deals legacy, and early indications suggest this transition is gaining traction.\"</li>\n<li>Morgan Stanley's Scott Devitt - after meetings with management - said the company <a href=\"http://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Makes+Positive+Comments+on+Groupon+%28GRPN%29/8963755.html\" target=\"_blank\">is making progress</a> on becoming a unique mobile commerce marketplace.</li>\n<li>He thinks it's a $15 stock by the end of next year thanks to improved deal quality and density in the U.S. and improvements internationally. Near-term, the site redesign is a positive tailwind.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1456961\" target=\"_blank\">Earlier coverage</a> from Devitt</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458441\" data-linked=\"Groupon gains amid positive sell-side calls\" data-tweet=\"$GRPN - Groupon gains amid positive sell-side calls https://seekingalpha.com/news/1458441-groupon-gains-amid-positive-sell-side-calls?source=tweet\" data-url=\"https://seekingalpha.com/news/1458441-groupon-gains-amid-positive-sell-side-calls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1458231\" data-ts=\"1386757843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1458231-world-shares-mixed-following-u-s-budget-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World shares mixed following U.S. budget deal</a></h4><ul>\n<li>Global equities are mixed as markets <a href=\"http://www.marketwatch.com/story/europe-stocks-struggle-for-green-amid-taper-talk-2013-12-11\" target=\"_blank\">mull the impact</a> of U.S. Congressional leaders agreeing to a budget deal.</li>\n<li>Such an agreement would normally be construed as a good thing, but not so when there's the Fed's QE to consider.</li>\n<li>\"The deal...would certainly have the potential to bring forward the prospect of tapering,\" says Interactive Investor's Rebecca O'Keeffe. This, in turn, would weigh on stocks.</li>\n<li>Asian shares are lower, with profit-taking also affecting shares. Japan <font color=\"red\">-0.6%</font>, Hong Kong <font color=\"red\">-1.7%</font>, China <font color=\"red\">-1.5%</font>, India <font color=\"red\">-0.4%</font>.</li>\n<li>EU Stoxx 50 <font color=\"green\">+0.3%</font>, London <font color=\"green\">+0.1%</font>, Paris <font color=\"green\">+0.7%</font>, Frankfurt <font color=\"green\">+0.2%</font>, Milan <font color=\"red\">-0.2%</font>, Madrid <font color=\"green\">+0.5%</font>.</li>\n<li>U.S. stock futures: Dow flat. S&amp;P flat. Nasdaq <font color=\"red\">-0.05%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1458231\" data-linked=\"World shares mixed following U.S. budget deal\" data-tweet=\"World shares mixed following U.S. budget deal https://seekingalpha.com/news/1458231-world-shares-mixed-following-u-s-budget-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1458231-world-shares-mixed-following-u-s-budget-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 AM </div></div></li>","count":59,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}